Welcome to our dedicated page for ALBANY INTERNATIONAL /DE/ SEC filings (Ticker: AIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ALBANY INTERNATIONAL /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ALBANY INTERNATIONAL /DE/'s regulatory disclosures and financial reporting.
Albany International Corp (AIN) reported that its Executive Vice President and Chief Financial Officer, Station Willard C, received 10,599 shares of Class A Common Stock on September 1, 2026 upon the vesting and conversion of Restricted Stock Units granted under the Albany International Corp. 2023 Plan. On March 1, 2026, 2,581 shares of Class A Common Stock were withheld at $54.33 per share to satisfy tax liabilities related to this equity award. The officer continues to hold multiple tranches of Restricted Stock Units covering 32,118, 6,370, and 9,023 underlying shares scheduled to vest between 2026 and 2029, and no Rule 10b5-1 trading plan is reported.
Albany International Corp. (AIN) completed its strategic review of the Amelia Earhart Drive facility in Salt Lake City and decided to retain the site. The decision follows new business wins, a renegotiated Boeing 787 fuselage-frame contract, and amended terms with Sikorsky on the CH-53K® helicopter program.
The amended CH-53K contract improves program financials, reduces risk, offsets projected losses, and is expected to generate positive cash flow beginning in 2027. Albany also reversed a portion of the forward loss reserve adjustment previously recorded on the CH-53K contract in its Engineered Composites segment.
Updated guidance for Q3 2026 keeps consolidated net revenue at $320–$330 million, while raising Adjusted EPS from prior guidance of $0.60–$0.70 to $1.40–$1.50, with an effective tax rate of 31.5%. For Q4 2026, Albany guides to consolidated net revenue of $325–$335 million, Adjusted EPS of $0.65–$0.75, and a 31.5% effective tax rate.
Albany International Corp. (AIN) reported that its Chief Financial Officer and principal financial officer, Willard Station, has begun a medical leave of absence effective August 31, 2026, and will not perform CFO duties during this period. The duration of the leave has not been determined.
Effective the same date, the Board appointed Sean Valashinas, the company’s Controller and Chief Accounting Officer, to serve as acting principal financial officer while continuing as principal accounting officer. Valashinas, age 55, has extensive prior experience in accounting, treasury, and tax roles at Resonetics and Standex International Corporation. The company states there are no disclosable familial relationships or related party transactions connected to his appointment and no changes to his compensation terms. A press release announcing these changes was furnished as Exhibit 99.1.
American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research report beneficial ownership of Albany International Corp. Class A Common Stock in this amended Schedule 13G filing. As of June 30, 2026, the group reports beneficial ownership of 1,859,631 shares, representing 6.6% of the Class A Common Stock. The reporting persons have sole voting power over 1,831,110 shares and sole dispositive power over 1,859,631 shares, with no shared voting or dispositive power. American Century Investment Management, Inc. is identified as an investment adviser and a wholly owned subsidiary of American Century Companies, Inc., which is controlled by the Stowers Institute for Medical Research. Various advisory clients of American Century Investment Management, Inc. are entitled to dividends and sale proceeds, but no single client is stated to own more than 5% of the class.
Albany International executive Christopher Eric Stone, President AEC, reported equity compensation activity in Albany International Corp. Class A Common Stock. On August 12, 2026, 6,905 Restricted Stock Units vested and were converted into 6,905 shares of Class A Common Stock, distributed pursuant to RSUs granted August 12, 2024 under the Albany International Corp. 2023 Plan. In a related transaction on March 1, 2026, 1,975 shares of Class A Common Stock were withheld at $63.84 per share to satisfy tax liabilities connected to this vesting. Stone continues to hold multiple tranches of Restricted Stock Units granted under the same plan, including awards tied to 3,867, 2,301, and 5,521 underlying shares, scheduled to vest in installments between 2025 and 2029.
Albany International Corp. reported higher results for the three and six months ended June 30, 2026. Net revenues were $329.5 million versus $311.4 million a year earlier, with six‑month revenues of $640.8 million versus $600.2 million. Net income attributable to the company rose to $17.4 million from $9.2 million for the quarter and to $32.7 million from $26.5 million year‑to‑date. Diluted EPS was $0.61 for the quarter and $1.14 for the six‑month period. Gross margin was 32.7% for the quarter and 32.4% year‑to‑date.
Machine Clothing segment net revenues were $178.7 million for the quarter and $344.7 million year‑to‑date, slightly below the prior year, while Albany Engineered Composites increased to $150.8 million and $296.2 million. AEC operating income improved to $11.4 million in the quarter and $20.0 million year‑to‑date, compared with losses in 2025, while Machine Clothing operating income decreased. Consolidated restructuring expenses rose to $8.0 million for the quarter and $11.1 million year‑to‑date, mainly from Machine Clothing site consolidations.
Net cash provided by operating activities for the first half was $3.0 million, down from $34.8 million, reflecting working capital uses. Cash and cash equivalents were $77.3 million and long‑term debt $450.7 million at June 30, 2026; the leverage ratio was 1.71 and interest coverage 8.07, within covenant limits. Assets and liabilities of the Amelia Earhart Drive facility in Salt Lake City remained classified as held for sale, with $306.7 million of assets and $187.1 million of liabilities.
Albany International Corp. reported stronger results for the quarter ended June 30, 2026. Net revenues were $329.5 million, up 6% from $311.4 million a year earlier, driven by higher volume in the Albany Engineered Composites business, partly offset by softer demand and downtime in Machine Clothing.
Net income attributable to the Company was $17.4 million, or $0.61 per diluted share, compared with $9.2 million, or $0.31, in Q2 2025. Adjusted diluted EPS rose to $0.82 from $0.57, and Adjusted EBITDA increased to $57.8 million from $51.9 million, lifting margin to 17.6% from 16.7%.
Machine Clothing net revenues declined 2.4% year over year on a constant-currency basis and its Adjusted EBITDA margin was 28.0%, or 29.0% on a constant-currency basis. Albany Engineered Composites net revenues grew 14.2% in constant currency and expanded Adjusted EBITDA margin to 13.3% from 8.5%. The Company ended the quarter with $77.3 million of cash, total debt of $450.7 million and net debt of $373.3 million. For the third quarter of 2026, Albany guides consolidated net revenue to $320–$330 million and Adjusted EPS to $0.60–$0.70.
Albany International Corp. CAO Sean C. Valashinas reported routine equity compensation activity. On June 9, 2026, he exercised 1,321 Restricted Stock Units into the same number of Class A common shares, then 315 shares were withheld at $69.52 each to cover related tax liability, resulting in a net increase of 1,006 shares and 1,204 Class A shares held directly.
He continues to hold multiple tranches of Restricted Stock Units that each convert into one Class A share upon vesting, including awards linked to June 9 and March 1 vesting dates in future years under the Albany International Corp. 2023 Plan.
Albany International Corp. director Christina M. Alvord reported an award of 2,390 Deferred Restricted Stock Units (DSUs) granted on May 15, 2026 under the company’s non-employee director compensation plans. Each DSU converts into one share of Class A Common Stock upon vesting.
After this grant, Alvord holds 2,792 shares of Class A Common Stock directly and 5,682 DSUs. The 2,390 new DSUs generally vest on the earlier of January 1, 2034, or upon specified events such as death, disability, or a change of ownership control, with alternative vesting terms if she separates from service earlier.
Albany International Corp. director Christina M. Alvord received a grant of 2,390 Deferred Restricted Stock Units (DSUs) on May 15, 2026 under the company’s Non-Employee Director Compensation Plan. Each DSU will convert into one share of Class A Common Stock at vesting, and the company will pay cash dividends on these DSUs as declared by the Board. The DSUs vest on the earlier of January 1, 2034, the director’s death or disability, or a change of ownership control, with 1,953 DSUs eligible to vest 20% annually over five years if she separates from service earlier. After this grant, she directly holds 5,682 DSUs and 2,792 Class A Common shares.